Microneedle Drug Delivery Systems Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Microneedle Drug Delivery Systems Market Size Changed, over the years?
Over the past few years, the microneedle drug delivery systems market has witnessed substantial growth. The market size is projected to rise from $5.01 billion in 2024 to $5.9 billion in 2025, representing a compound annual growth rate (CAGR) of 17.9%. Factors contributing to this growth during the historic period include painless drug delivery, improved patient adherence, management of chronic diseases, cosmetic and aesthetic utilization, and vaccine distribution.
How Much Will the Microneedle Drug Delivery Systems Market Be Worth in 2029?
We can anticipate a swift expansion in the microneedle drug delivery systems market in the forthcoming years. In 2029, the predicted growth hits a staggering $11.44 billion, displaying a compound annual growth rate (CAGR) of 18.0%. Factors contributing to this projected growth during the forecast period include the use in cosmetic and aesthetic applications, the rise of emerging therapies, utilization in pediatric and geriatric care, worldwide health initiatives, and point-of-care testing. Smart microneedles, advancements in material science, wearable technology progression, the use of biodegradable materials, and continuous glucose monitoring will shape the main trends in this expected period.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5338&type=smp
Which is the Largest Company in the Microneedle Drug Delivery Systems Market?
Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.
What Are the Main Market Drivers in the Microneedle Drug Delivery Systems Industry?
The escalating interest in research and the increased need for effective vaccination methods are both forecasted to fuel the expansion of the microneedle drug delivery systems market. Experts regard microneedles as an alternate method of vaccine delivery aimed at eliminating any discomfort experienced by the recipient. Though the microneedle patch was initially designed for flu and measles vaccines, it’s increasingly used for COVID-19 vaccine administration. For illustration, in April 2024, the Office for National Statistics, a UK government agency, reported a surge in the UK government’s net expenditure on research and development (R&D). Excluding contributions to the EU R&D fund, this increase amounted to $17.01 billion (£15.5 billion) in 2022, a 10.5% jump from $15.37 billion (£14.0 billion) in 2021. By factoring contributions to the EU R&D budget and knowledge transfer activities, the total net expenditure on R&D reached $18.006 billion (£16.4 billion) in 2022, an 8.9% growth from $16.46 billion (£15.0 billion) in 2021. Consequently, the uptick in research interest and vaccine demand is propelling the microneedle drug delivery systems market forward.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=5338&type=smp
How Is the Microneedle Drug Delivery Systems Market Segments Structured?
The microneedle drug delivery systems market covered in this report is segmented –
1) By Technology: Hollow, Porous, Solid, Other Technologies
2) By Application: Drug Delivery, Vaccine Delivery, Other Applications
3) By End-User: Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Hollow: Solid Hollow Microneedles, Coated Hollow Microneedles
2) By Porous: Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
3) By Solid: Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
4) By Other Technologies: Dissolving Microneedles, Biodegradable Microneedles, Micro-Infusion Systems
What Strategic Trends Are Transforming the Microneedle Drug Delivery Systems Market?
Leading firms in the realm of microneedle drug delivery systems are putting their focus on product innovation, with a particular emphasis on radiofrequency microneedle systems, to provide sound services for their client base. The radiofrequency microneedle system is a minimally invasive technique that merges microneedles and radiofrequency energy, augmenting drug delivery and augmenting collagen generation in the skin for both therapeutic and cosmetic purposes. Candela, a prominent medical aesthetic device company based in the US, for instance, in February 2023, unveiled the Profound Matrix system. This versatile system assimilates the Sublime, Sublative RF, and the groundbreaking Matrix Pro applicators. The Sublime and Sublative RF make good use of bipolar radiofrequency (RF) technology to boost the look of fine lines and wrinkles, whereas the Matrix Pro applicator lays emphasis on rejuvenating and boosting collagen production. The system is equipped with a cluster of thin microneedles that deliver short-pulse RF energy to the skin, bringing about increased patient comfort, minimized downtime, and better overall outcomes.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Microneedle Drug Delivery Systems Market?
North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5338
This Report Delivers Insight On:
1. How big is the microneedle drug delivery systems market, and how is it changing globally?
2. Who are the major companies in the microneedle drug delivery systems market, and how are they performing?
3. What are the key opportunities and risks in the microneedle drug delivery systems market right now?
4. Which products or customer segments are growing the most in the microneedle drug delivery systems market?
5. What factors are helping or slowing down the growth of the microneedle drug delivery systems market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model